ATR – aptargroup, inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ATR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

6/19

08:24 am

atr

[Latest] US Caps and Closures Market Size/Share Worth USD 6,645.7 Million by 2034 at a 4.82% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]

Low Report

Report

6/19

04:23 am

atr

Aerosol Valves Global Strategic Business Report 2025 | Revenues to Reach US$2.4 Billion by 2030 | Smart Aerosol Valve Technologies Accelerate Demand for Connected Solutions [Yahoo! Finance]

Low Report

Aerosol Valves Global Strategic Business Report 2025 | Revenues to Reach US$2.4 Billion by 2030 | Smart Aerosol Valve Technologies Accelerate Demand for Connected Solutions [Yahoo! Finance]

Report

6/2

05:00 pm

atr

Aptar to Participate in Upcoming Investor Conferences

Low Report

Aptar to Participate in Upcoming Investor Conferences

Report

5/29

05:00 pm

atr

Aptar Releases 2024 Corporate Sustainability Report

Low Report

Aptar Releases 2024 Corporate Sustainability Report

Report

5/20

12:06 pm

atr

Is AptarGroup (ATR) Outperforming Other Industrial Products Stocks This Year? [Yahoo! Finance]

Low Report

Is AptarGroup (ATR) Outperforming Other Industrial Products Stocks This Year? [Yahoo! Finance]

Report

5/15

12:06 am

atr

AptarGroup, Inc. (NYSE: ATR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Low Report

AptarGroup, Inc. (NYSE: ATR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Report

5/6

09:14 am

atr

AptarGroup, Inc. (NYSE: ATR) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.

Low Report

AptarGroup, Inc. (NYSE: ATR) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.

Report

5/5

11:08 pm

atr

AptarGroup, Inc. (NYSE: ATR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Low Report

AptarGroup, Inc. (NYSE: ATR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Report

5/1

05:29 pm

atr

AptarGroup: Q1 Earnings Snapshot [Yahoo! Finance]

Low Report

AptarGroup: Q1 Earnings Snapshot [Yahoo! Finance]

Report

5/1

05:14 pm

atr

Aptar Reports First Quarter 2025 Results [Yahoo! Finance]

Low Report

Aptar Reports First Quarter 2025 Results [Yahoo! Finance]

Report

5/1

05:03 pm

atr

Aptar Reports First Quarter 2025 Results

Low Report

Aptar Reports First Quarter 2025 Results

Report

4/24

12:13 pm

atr

AptarGroup (ATR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]

Low Report

AptarGroup (ATR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]

Report

4/22

01:09 pm

atr

AptarGroup, Inc. (NYSE: ATR) had its price target lowered by analysts at Raymond James from $190.00 to $175.00. They now have an "outperform" rating on the stock.

Low Report

AptarGroup, Inc. (NYSE: ATR) had its price target lowered by analysts at Raymond James from $190.00 to $175.00. They now have an "outperform" rating on the stock.

Report

4/17

05:00 pm

atr

Aptar Declares Quarterly Dividend

Low Report

Aptar Declares Quarterly Dividend

Report

4/16

01:51 pm

atr

Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]

Low Report

Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]

Report

4/16

08:34 am

atr

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers [Yahoo! Finance]

Low Report

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers [Yahoo! Finance]

Report

4/16

08:00 am

atr

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

Low Report

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

Report

4/15

05:00 pm

atr

Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

Low Report

Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

Report

4/14

08:24 am

atr

Positive Adherence Impact of IPUMP® Connected Assistant for Sublingual Liquid Allergen Immunotherapy Treatment [Yahoo! Finance]

Low Report

Positive Adherence Impact of IPUMP® Connected Assistant for Sublingual Liquid Allergen Immunotherapy Treatment [Yahoo! Finance]

Report

4/14

08:24 am

atr

Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence [Yahoo! Finance]

Low Report

Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence [Yahoo! Finance]

Report

4/8

03:32 pm

atr

Medical Rubber Stoppers Market Size Worth USD 1619 Million by 2030 - CAGR 4.8% | Free Sample Report Inside - Valuates Reports [Yahoo! Finance]

Low Report

Medical Rubber Stoppers Market Size Worth USD 1619 Million by 2030 - CAGR 4.8% | Free Sample Report Inside - Valuates Reports [Yahoo! Finance]

Report

3/27

05:00 pm

atr

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year

Low Report

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.